Aligos Therapeutics (ALGS) Earnings Date & Reports

Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ALGS is expected to report earnings to rise 1,464.29% to -219 cents per share on November 05

Aligos Therapeutics ALGS Stock Earnings Reports

Q3'26

Est.

$-2.19

Q2'26

Beat

by $1.01

Q1'26

Beat

by $1.08

Q4'25

Missed

by $1.66

Q3'25

Missed

by $2.79

The last earnings report on August 06 showed earnings per share of -14 cents, beating the estimate of -114 cents. With 14.68K shares outstanding, the current market capitalization sits at 34.59M.

View a ticker or compare two or three

ALGS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ALGS